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Background: Metabolic homeostasis in mammals critically depends on the regulation of fasting-induced genes by
CREB in the liver. Previous genome-wide analysis has shown that only a small percentage of CREB target genes are
induced in response to fasting-associated signaling pathways. The precise molecular mechanisms by which CREB
specifically targets these genes in response to alternating hormonal cues remain to be elucidated.
Results: We performed chromatin immunoprecipitation coupled to high-throughput sequencing of CREB in livers
from both fasted and re-fed mice. In order to quantitatively compare the extent of CREB-DNA interactions
genome-wide between these two physiological conditions we developed a novel, robust analysis method, termed
the ‘single sample independence’ (SSI) test that greatly reduced the number of false-positive peaks. We found that
CREB remains constitutively bound to its target genes in the liver regardless of the metabolic state. Integration of
the CREB cistrome with expression microarrays of fasted and re-fed mouse livers and ChIP-seq data for additional
transcription factors revealed that the gene expression switches between the two metabolic states are associated
with co-localization of additional transcription factors at CREB sites.
Conclusions: Our results support a model in which CREB is constitutively bound to thousands of target genes, and
combinatorial interactions between DNA-binding factors are necessary to achieve the specific transcriptional
response of the liver to fasting. Furthermore, our genome-wide analysis identifies thousands of novel CREB target
genes in liver, and suggests a previously unknown role for CREB in regulating ER stress genes in response to
nutrient influx.
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The cAMP-response element binding protein (CREB) is
a highly conserved effector of transcriptional changes in
response to cAMP signaling in a wide range of physio-
logical processes and cell types [1-4]. Increased cAMP
levels cause activation of Protein Kinase A (PKA), which
phosphorylates CREB on Serine 133 (S133), thereby pro-
moting interactions with the co-activators and histone
acetyltransferases CREB-binding protein (CREBBP), E1A* Correspondence: kaestner@mail.med.upenn.edu
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reproduction in any medium, provided the orbinding protein p300 (EP300), and CREB-regulated tran-
scription co-activator 2 (CRTC2) [1,5]. Although CREB
binding and phosphorylation has been observed at thou-
sands of genes, the majority of CREB target genes are
not induced by cAMP in vivo [6]. In vitro studies have
suggested that phosphorylation of S133 also promotes
CREB binding to specific DNA sequences [7], providing
a potential mechanism by which cAMP induces the ex-
pression of some CREB target genes, but not others.
Supporting this notion, a small number of CREB target
genes were shown to exhibit increased binding in the
liver of fasted animals [8]. However, CREB binding dy-
namics have not been explored genome-wide, and the
precise molecular mechanisms that direct this PKA-Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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genes in a context-specific manner remain to be elucidated.
In the liver, CREB plays a central role in the mainte-
nance of glucose homeostasis, and dysregulation of the
CREB-dependent gluconeogenic gene program is a con-
tributing factor in a number of metabolic diseases in-
cluding type 2 diabetes [9-12]. A drop in blood glucose
levels triggers a glucagon/epinephrine-dependent signaling
cascade resulting in the cAMP-induced phosphorylation
of CREB S133 in hepatocytes to induce the expression of
key gluconeogenic genes [1,13]. Previous genome-wide
studies in primary hepatocytes have shown that CREB
binds to thousands of target gene promoters, while only a
small subset of these genes are induced by cAMP [6,14].
However, these studies did not examine changes in CREB
DNA binding and did not identify features separating
cAMP-inducible and non-inducible CREB targets. Further-
more, these studies used chromatin immunoprecipitation
coupled to genomic microarrays (ChIP-chip) technology,
which was limited to the promoter regions of known genes
and showed limited sensitivity even within these regions.
To address the question of whether CREB DNA binding
dynamics play a role in fasting-induced gene expression,
we performed chromatin immunoprecipitation coupled to
high-throughput sequencing (ChIP-seq) and gene expres-
sion analysis by microarray on mouse livers in both fasted
(high glucagon/insulin ratio) and re-fed conditions (low
glucagon/insulin ratio). Controlled fasting and re-feeding
has been shown to be a robust model of cAMP-dependent
CREB activity in the mammalian liver [15,16], and ChIP-
seq provides a major improvement in the sensitivity and
resolution of CREB binding site detection compared to
previous ChIP-chip studies. Our results demonstrate that
global CREB DNA binding in the liver is independent
of cAMP/PKA-signaling, and support a model in which
CREB remains constitutively bound to DNA irrespective of
its phosphorylation state. Strikingly, we also discovered
CREB binding at thousands of novel target genes, including
genes that are transcriptionally repressed in the fasted liver
versus the re-fed liver. To further elucidate how CREB spe-
cifically regulates subsets of target genes, we performed an
integrative computational analysis of the CREB cistrome
and fasting-dependent transcriptome in mouse livers to
identify genomic features correlated with CREB sites at
fasting-responsive genes. In particular, we observed a
strong enrichment for binding of additional transcription
factors proximal to the CREB sites specifically at fasting-
responsive genes, suggesting that the cooperation between
transcriptional regulators at the level of individual regula-
tory elements — as opposed to entire promoters — is more
widespread and critical to gene induction than previously
demonstrated. Our work represents an integrative para-
digm for studying the context-dependent role of a tran-
scriptional regulator in a specific physiological process.Results
Genome-wide CREB-DNA binding is independent of
cAMP/PKA-signaling
Two models have been proposed as to how CREB con-
tributes to gene activation in response to cAMP stimuli.
Early studies found CRE “half-sites”, composed of only
five of the eight nucleotides of the consensus CRE, were
bound more tightly by CREB phosphorylated on S133
than by unphosphorylated CREB in vitro [7], suggesting
that partial CRE motifs play a critical role in cAMP-
dependent gene induction. In vivo studies have observed
both dynamic [8] and constitutive CREB binding to
DNA [17,18], but these studies only tested a small subset
of known CREB target genes. Genome-wide studies of
CREB in hepatocytes have not examined CREB DNA
binding dynamics, but have shown that CREB binds a
large proportion of gene promoters that are not induced
by cAMP [6,14]. We therefore began our investigation
by examining the genome-wide profiles of CREB binding
to DNA in response to fasting-induced cAMP signaling
to test comprehensively if site-specific dynamic CREB
binding could be observed in vivo.
In order to quantitatively test genome-wide binding of
CREB in both the fasted (cAMP/PKA-active) and re-fed
(cAMP/PKA-inactive) states, we performed a controlled
feeding experiment (Figure 1A) in which 10 mice were
fasted for 24 hours, and either immediately sacrificed
(fasted group), or fed again for two hours before sacri-
ficing (re-fed group). We observed a robust and consis-
tent decrease in blood glucose for the fasted mice relative
to the re-fed mice (Figure 1B), and RT-PCR measure-
ments confirmed induction of well-characterized cAMP-
responsive genes G6pc [19], Pck1 [20,21], and Ppargc1a
[13] in the livers of fasted mice (Figure 1C). Western blot
analysis showed that CREB phosphorylation at S133, indi-
cating activation of the cAMP/PKA pathway, was also
specific to the fasted state as expected and not to the re-
fed state (Figure 1D), in contrast to what has been
reported previously after acute insulin injections intended
to mimic the re-fed state [5]. Liver chromatin from indi-
vidual mice was subsequently used to perform ChIP-seq
with an antibody recognizing CREB, regardless of phos-
phorylation status.
The large number of biological replicates included in our
ChIP-seq study allowed us to apply a novel peak-calling
and filtering strategy that removes non-reproducible peaks,
while maintaining detection sensitivity across a wide range
of enrichment strengths. Under our strategy, termed the
“Single-Sample Independence (SSI) test”, sequence reads
from all five fasted or re-fed replicates were first pooled
together and used in peak-calling to identify all candidate
CREB binding events. This was followed by a filtering
step in which each peak was retained only if a similar peak
was called after excluding any individual replicate from
Figure 1 Experimental design and validation. A) Overview of experimental design. A cohort of 10 male C57BL/6J mice was fasted for
24 hours, then split into fasted and re-fed groups (n=5 each). The fasted mice were immediately sacrificed, while the re-fed group was given
access to food for 2 hours before sacrificing. Blood glucose measurements were taken from all mice prior to sacrifice. Livers were collected
shortly after sacrifice, and used for both mRNA and ChIP-seq experiments. B) Blood glucose was significantly higher in re-fed animals. Error bars
indicate SEM, *p < 1E-4, one-tailed Student’s t-test. C) Known fasting-induced gluconeogenic genes are significantly induced in the fasted state
(white bars) relative to the re-fed state (black bars) by RT-PCR. Error bars indicate SEM, *p < 0.005, one-tailed Student’s t-test). D) Western blot
analysis of mouse livers shows that CREB is strongly phosphorylated on Ser133 after a 24 hr fast, but not after 2 hour re-feeding. Western blot
was re-probed with an antibody for total CREB to validate equal loading.
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This filtering strategy removed greater than 50% of the ini-
tial peak calls, and resulted in a much stricter set of target
sites than would be obtained by simply applying a more
conservative false discovery rate cutoff to the initial candi-
date peak calls, while also taking advantage of the bio-
logical replicate structure of the data set (Additional file 1:
Table S1). The peak calls eliminated by our SSI strategy
typically occurred at sites inconsistent with known CREB
biology in terms of the occurrence of known motifs
and bias toward promoter regions, showed less overlap
between the fasted and re-fed states, less overlap with
ENCODE DNaseI-hypersensitive (DHS) regions [22,23]
(Additional file 1: Figure S1B, HOMER columns), and
tended to fall in a weaker range of peak heights below
0.5 reads per million (RPM) (Additional file 1: Figure S1C).
The SSI strategy can be applied using any peak-calling
algorithm; we tested the SSI filter using the previously
published peak-calling tools HOMER [24], GLITR [25],and MACS [26]. While the results were comparable
using any of these peak-calling algorithms, the HOMER+
SSI combination resulted in the smallest number of
algorithm-specific peaks, and the set of sites with the
highest occurrence of known CREB motifs (Additional
file 1: Figure S1B,D). We also assessed the number of
peaks filtered out after excluding each individual replicate
and found a similar percentage of sites are dependent on
each replicate, confirming that each replicate is of com-
parable quality (Additional file 1: Figure S1E). Therefore,
the peaks called by HOMER+SSI using all replicates were
used for further analysis.
We further validated our SSI-filtered peak calls by
performing ChIP-qPCR on randomly selected peaks across
the range of peak heights. Importantly, these validation ex-
periments showed that peaks with an average peak height
below 0.35 RPM (the bottom quartile of SSI-filtered peaks)
were not reproducible, while peaks above this cutoff had a
high rate of reproducibility (Additional file 1: Figure S2).
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lapped ENCODE DHS regions in mouse liver [22,23], sug-
gesting that the majority of these sites represent real
binding events. Overall, our extensive peak-filtering strat-
egy identified 6,835 and 5,357 high-confidence CREB bind-
ing sites in the fasted and re-fed states, respectively.
Our high-confidence peak calls from the fasted and re-
fed replicates exhibited 62% overlap (Figure 2A), at first
glance suggesting that thousands of CREB binding sites
may depend on CREB phosphorylation level, as pro-
posed originally by Nichols and colleagues [7]. However,
the absence of a peak call in one condition, though fre-
quently employed in the literature [27-29], is not a suffi-
cient criterion for demonstrating differential binding,
because peak-calling algorithms provide no estimate of
the false negative rate. In other words, these apparently
“differentially bound” regions may actually indicate cases
in which the peak call was simply missed in one of the
two conditions. To address this issue directly, we mergedFigure 2 Differential CREB binding analysis. A) Venn diagram of high-c
liver suggests thousands of condition-specific binding events. B) Flowchart
(RPM = reads per million) across all fasted and re-fed replicates, for 7,547 m
red dots correspond to peaks called only in the fasted group, and blue do
indicate SEM. D) Boxplot of log2 fasted/re-fed ratio of peak height for subs
CRE sequence within 50 bp of peak center. E) ChIP-qPCR of CREB binding
CREB target genes. Neither change is significant at p-value of 0.05 thresholtogether all fasted and re-fed peak calls to obtain a total of
7,547 high-confidence CREB binding sites, and quantified
the extent of ChIP-seq signal at each site, in each replicate,
under each condition (Figure 2B). As revealed by the
scatterplot of average fasted versus average re-fed ChIP-
seq peak height (Figure 2C), the strength of CREB binding
at any site was highly comparable between the two condi-
tions, with only a weak global induction (median = 1.3-
fold) of CREB binding in the fasted state. Sites that were
originally specified as condition-specific occurred pre-
dominantly in the lower range of peak heights, where false
negative calls by peak-calling algorithms are most likely,
and the peak strength in the other condition tended to be
comparable despite the lack of a complementary site call.
Furthermore, we observed a less than a 1.1-fold difference
in the median fasting/re-fed CREB binding ratio when
comparing subsets of CREB sites separated by CRE motif
occurrence (Figure 2D), further contradicting the model
proposed by Nichols and colleagues [7].onfidence CREB site calls in the re-fed (blue) and fasted (red) mouse
of quantitative analysis. C) Scatter-plot of average peak height
erged peaks. Black dots correspond to peaks called in both conditions,
ts correspond to peaks called only in the re-fed group. Gray error bars
ets of CREB binding sites based on occurrence of canonical full or half
in the re-fed (blue) and fasted (red) groups on known fasting-induced
d (one-tailed Student’s t-test).
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the known cAMP-inducible genes Pck1 and Ppargc1a in
both metabolic states confirmed the constitutive binding
pattern observed in our ChIP-seq experiment (Figure 2E).
We also analyzed individual peaks for differential bind-
ing across conditions using the EdgeR tool [30], but
were only able to identify 12 regions (0.2% of total) with
significant differential CREB enrichment at a 10% FDR
threshold (Additional file 1: Table S2). Of these 12 differ-
ential peaks, 3 were greater than 10 kb away from any
known genes, and another 3 were within 500 bp of a
separate peak that did not pass the EdgeR 10% FDR
threshold for differential enrichment. Therefore, we con-
clude that differential binding of CREB in response to
cAMP-dependent phosphorylation does not play a critical
genome-wide role in fasting-induced gene expression.
Our quantitative analysis demonstrates that total CREB
binding to DNA in liver is, at most, only weakly induced
by fasting-dependent signaling, with minimal sequence or
site specificity. Given that we observed substantially larger
differences in target gene expression in the same experi-
ment (Figure 1C), it is highly unlikely that dynamic bind-
ing at specific sites is the primary regulatory mechanism
for the specific induction of cAMP-responsive genes by
CREB in vivo.
CREB ChIP-seq in liver reveals novel target genes and
binding elements
Having established that CREB binding to its target genes
is largely independent of its activation state in the liver,
we used the 7,547 CREB binding sites identified across
both physiological conditions to further investigate the
hepatic CREB cistrome. Reassuringly, our high-confidence
peak calls include binding sites corresponding to many
known target genes, including Pck1, Ppargc1a, and Crem
(Additional file 1: Figure S3). We compared the hepatic
CREB cistrome to all known gene loci and found that
CREB binding is highly biased towards known promoter
regions (66% of sites), with particular enrichment of sites
500 bp upstream to 200 bp downstream of transcription
start sites (TSS) (Figure 3A,B). CREB binding events in
the remainder of the 5’ UTR (greater than 200 bp down-
stream of TSS), coding exons, or 3’ UTRs were extremely
rare. A substantial portion of the remaining sites (15% of
total) fell into intronic regions, with more than half of
these events occurring in the first intron of a known tran-
script (Figure 3A,C). The remaining CREB sites (15%)
were intergenic, with the majority of these sites within
50 kb of a known TSS (Figure 3A,D). A previous analysis
of the CREB cistrome in rat neurons using serial analysis
of chromatin occupancy (SACO) had suggested a much
higher percentage of intergenic sites [31]. This difference
can be explained in part by the limited gene annotations
available at the time of the prior study, as well asdifferences in the cell type used and in the higher accuracy
of ChIP-seq versus SACO. A more recent ChIP-seq study
of CREB binding in murine male germ-line cells found a
similar number of bound sites and similar rates of pro-
moter and intron overlap as our liver cistrome [32]. Over-
all, our analysis suggests that in the liver most CREB sites
are linked to the regulation of known genes via upstream
or internal promoters.
We considered any gene with a CREB peak inside the
gene body or up to 10 kb upstream of the TSS to be a
CREB target gene in liver, resulting in a total of 7,095
target genes that we compared to previous genome-wide
studies (Figure 3E). Strikingly, only 14% of these target
genes were previously observed as bound by CREB in a
ChIP-chip study of human hepatocytes [6], even after
mapping gene regions between these studies to remove
bias from updated or species-specific gene annotations.
30% of the target genes in our analysis were observed in
other mammalian cell types but not hepatocytes [6,32],
and 18% were predicted only by bioinformatic sequence
analysis but never demonstrated by in vivo genome-wide
experiments [6]. A substantial portion of target genes
(37.4%) had never been observed or predicted as CREB-
bound in previous genome-wide studies.
To assess the motif content of the CREB cistrome, we
first searched for instances of the canonical CRE motif
within +/−50 bp of peak centers. We considered matches
to the 8mer ‘TGACGTCA’ with up to 1 mismatched nu-
cleotide to be “Full CRE” sequences, and exact matches to
the 5mer ‘TGACG’ to be “Half CRE” sequences. These
sequences were found under the majority of our peaks,
although surprisingly more than a third of all high-
confidence CREB sites lacked an apparent CRE motif
(Figure 4A). The strength of CREB binding generally
depends on this primary motif, as sites containing a Full
CRE have a higher distribution of peak heights and sites
lacking any CRE have a lower distribution of peak heights
(Figure 4B).
De novo motif analysis of the CREB cistrome confirmed
the enrichment of Full and Half CRE sequences as the top
motifs, along with several other known promoter features
such as GC-Box and ‘CCAAT’ motifs (Figure 4C). To fur-
ther investigate the sites lacking canonical binding se-
quences, we repeated the de novo motif analysis on only
those sites without a CRE sequence match. We found a
more degenerate CRE sequence as the top motif among
these sites, but otherwise revealed the same motifs as the
whole cistrome analysis, although the GC-Box motif was
more enriched among these sites (Figure 4D). Positional
enrichment analysis showed that the canonical CRE mo-
tifs are highly biased towards peak centers, but show no
enrichment in the regions immediately flanking the peaks,
as expected for a primary binding motif (Additional file 1:
Figure S4A,B). Interestingly, the degenerate CRE also
Figure 3 Hepatic CREB binding relative to gene structure. A) The proportion of 7,547 high-confidence CREB binding sites with peak center in
promoter regions (green, defined as -2 kb to +200 bp around TSS), 5’ UTR (orange), exons (red), introns (blue), and 3’ UTR (yellow). The remaining sites
are considered intergenic (gray). B) Frequency of CREB binding site positions relative to known TSS. Colors correspond to feature definitions used in
(A). C) Proportion of intronic CREB sites occurring in the first intron of a known transcript. D) Proportion of intergenic CREB sites occurring within 50 kb
of a known TSS. E) We identified 7,095 genes bound by CREB at distal, proximal, or internal sites based on our high-confidence ChIP-seq peaks.
Pie chart shows the proportion of target genes previously identified in liver cells [6], other mammalian cell types [6,32], or predicted by bioinformatics
analysis [6]. The remaining 2,641 CREB-bound genes were not identified or predicted in the previous genome-wide studies.
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among the sites lacking a canonical CRE, suggesting that
these degenerate consensus sequences are still directly
recognized by the CREB protein (Additional file 1: Figure
S4C). The additional de novo motifs corresponding to other
DNA-binding factors also show positional bias around
CREB sites, although they tend to be more widely distrib-
uted compared to CRE motifs (Additional file 1: Figure
S4D-F). Overall, these results suggest that CREB binding to
DNA is more promiscuous than previously appreciated,
and CREB may cooperatively or indirectly bind DNA with
additional factors at a subset of target sites.
CREB binding alone is insufficient to confer fasting-
responsiveness to target genes
Given that our CREB ChIP-seq data indicated very few
significant changes in target occupancy in response tothe fasting-induced cAMP/PKA signal, we next used ex-
pression microarrays to identify which CREB targets are
induced during fasting. We directly compared gene ex-
pression patterns between mouse livers in the fasted and
re-fed conditions, and observed significant changes in
942 genes, including the aforementioned cAMP-inducible
targets Pck1, Ppargc1a, and G6pc (Figure 5A, Additional
file 2). We also observed reduced expression of many ER
stress genes, such as Hspa5 (Grp78/Bip), Hspa1a, and
Creld2, in the fasted state relative to the re-fed state, in
agreement with previous findings that nutrient influx dur-
ing re-feeding induces mild ER stress [33,34].
We next compared our expression microarray results
to the high-confidence CREB binding sites determined
by our ChIP-seq analysis. We found that, in general,
both genes that are induced or repressed in the fasted
state are enriched for nearby CREB binding (Figure 5B;
Figure 4 Motif analysis of CREB binding sites. A) Percentage of binding sites containing a Full CRE (‘TGACGTCA’ with at most one mismatch),
Half CRE only (‘TGACG’ exact match), or neither type of CRE within +/- 50 bp of peak center. B) Distribution of peak heights within each category
of site identified by sequence content in (A). C) Top five de novo motifs returned by HOMER for the 7,547 high-confidence CREB binding sites in
the liver. Sites with the same rank were clustered together as similar motifs by HOMER. Percentage of binding sites and P-value were calculated
using the optimal motif score threshold as determined by HOMER. D) Top de novo motifs returned by HOMER for the 3,155 high-confidence
CREB binding sites lacking a canonical CRE sequence in (A).
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binding around fasting-repressed sites is particularly sur-
prising, given that CREB has been reported to function
solely as an activator of gene expression [1]. In total, 285
(4%) CREB binding sites were associated with fasting-
induced genes, and therefore considered to be the most
likely cAMP-responsive sites in liver. Another 321 (4%)
sites were associated with fasting-repressed genes, and
6,018 (80%) sites were associated with genes not signifi-
cantly altered in our microarray experiment. Thus, it
appears that only a small subset of CREB binding sites
are involved in conveying the cAMP signal to control
gene expression in the liver, despite the observation that
the majority of CREB sites are in known promoter
regions (Figure 3A,B). Given that CREB-DNA interac-
tions do not change significantly at the majority (>99%) of
sites in response to cAMP signaling (Figure 2, Additional
file 1: Table S2), and that the co-activators CREBBP,
EP300, and CRTC2 have no inherent sequence specificity,
this result strongly supports the conclusion that othergenomic features, in addition to the presence of CREB
binding, are required for cAMP-responsive changes in
gene expression.
To investigate the mechanism of specificity of the cAMP-
response, we tested for the enrichment of various genomic
features within the three subsets of CREB sites associated
with fasting-induced, repressed, or non-responsive genes
defined above. We found only minor differences in the
occurrence of CRE motifs and intronic versus promoter po-
sitioning of sites (Figure 6A,B). Thus, differences in the se-
quence content and relative positioning of CREB binding
sites do not explain the specificity of the observed expres-
sion response as had been proposed previously [6,35].
Previous results on a small set of known targets had
suggested that only promoters containing a TATA-box
are inducible by a CRE site [18]. We classified all gene
promoters in our analysis as TATA-containing or TATA-
less, and again found only a weak association with fasting-
responsive CREB targets. Specifically, while CREB-bound
TATA-containing genes are the most likely to be induced
Figure 5 Enrichment of CREB binding around fasting-responsive genes. A) Heatmap of genes called as differentially expressed in fasted
versus re-fed liver microarray experiment. Known fasting-inducible CREB targets are shown on top right. Selected feeding-inducible and ER stress
genes are shown at bottom right. Number of genes and associated CREB sites are shown on left. B) For each gene category (fasting-induced in red,
fasting-repressed in green, and all genes on the microarray in gray), we computed the percentage of genes containing 1, 2, or 3+ high-confidence
CREB binding sites anywhere in the 10 kb TSS upstream region or the gene body (including introns). ~60% of regulated genes (both fasting-induced
and fasting-repressed) have at least one CREB binding site by this criteria, while 33% of all genes on the array can be associated with at least one CREB
binding site. *p-value < 1E-5 by Fisher’s Exact Test versus gray bars. NS indicates p-value > 0.05. A full listing of differentially expressed genes and
associated CREB binding is provided in Additional file 2.
Figure 6 Association of CREB binding sites with fasting-responsive TATA-box containing promoters. CREB sites were separated into
3 groups: 285 sites associated with genes up-regulated in fasted state (red), 321 sites associated with genes down-regulated in fasted state
(green), and 6,018 sites associated with genes that did not change (gray). A) Rates of CRE motif sequences (either full CRE or half CRE) identified
for each group of CREB sites. *p-value < 0.05 by Fisher’s exact test versus the ‘No Change’ group. B) Rates of CREB sites, separated by association
with fasting-dependent regulation, occurring in proximal promoter (−2 kb to +200 bp around TSS), distal promoter (−10 kb to -2 kb upstream of
TSS), intronic, and exonic regions. *p-value < 0.001 by Fisher’s exact test compared to corresponding gray bar. C) All genes on our microarray
were separated into groups based on associated CREB binding and presence of a TATA-box in the promoter. For each group, the percentage of
genes induced (red) and repressed (green) in response to fasting is shown. *p-value < 1E-11, by Fisher’s Exact Test against the CREB-/TATA- group. NS
indicates p-value > 0.05.
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cantly enriched for fasting-responsive genes, and CREB-
bound TATA-containing genes are equally enriched among
fasting-repressed genes (Figure 6C), suggesting that the
mechanism for specificity is more complex than previously
proposed.
Combinatorial transcription factor binding determines
gene regulation in response to the fasting-feeding switch
in the liver
Based on the results above, we hypothesized that additional
sequence-specific transcription factors may contribute to
the specificity of the fasting response at a subset of CREB
sites. Previous work, focused on several well-studied pro-
moters, had shown synergistic effects of CRE sequences
with other transcription factor binding sites [8,20,36,37].
We therefore tested the enrichment of binding by other
transcription factors involved in the hepatic fasting re-
sponse around CREB binding sites. We used previously
published ChIP-seq data for forkhead box protein A2
(FOXA2) [25,38] and peroxisome proliferator activated
receptor alpha (PPARA) [39], and performed additional
ChIP-seq experiments for the glucocorticoid receptor
(NR3C1/GR) and CCAAT/enhancer-binding protein beta
(CEBPB), as these factors have all been shown to play a
major role in the response to fasting in mammalian liver
[8,40-42].
The binding strength of CREB itself showed no associ-
ation with the differential expression of the correspond-
ing target gene in the hepatic feeding to fasting switch
(Figure 7A, Additional file 1: Figures S6 and S7A, Add-
itional file 3). The situation was strikingly different, how-
ever, for CEBPB, PPARA, NR3C1/GR and FOXA2,
binding of all of which was much stronger near CREB
binding sites associated with the genes induced in re-
sponse to fasting compared to all others, with the greatest
differential observed for FOXA2 (Figure 7B-E; Additional
file 1: Figure S7B-E ). In contrast, binding of the Zinc-
finger transcription factor CTCF in the mouse liver
[22,23], while also generally enriched near CREB binding
sites, did not correlate with the inducibility of CREB target
genes after fasting (Figure 7F, Additional file 1: Figure
S7F). Overall, our results suggest that the combinatorial
action of a group of transcription factors is responsible for
the induction of a small subset of CREB-bound promoters
in the liver, and the simple presence of a CRE or even a
proven CREB binding event is not sufficient to determine
whether the associated gene is part of the fasting response.
We performed additional de novo motif analysis of
CREB sites, directly comparing those sites associated
with fasting-induced and -repressed genes to the non-
responsive sites, and also computed the group-wise en-
richment of the additional de novo motifs identified from
the entire CREB cistrome (Figure 7G). We did not findany additional motifs specifically associated with fasting-
induced sites, but we observed a significant enrichment
for a motif at feeding-induced sites matching the half-
site recognized by the Maf family of transcription factors
[43]. We also observed that the ETS family motif is specific-
ally depleted around CREB sites associated with fasting-
induced genes, while the ‘CCAAT’ motif is slightly enriched
at feeding-induced sites, although not to the same extent as
the Maf family motif. Collectively, these results suggest that
transcription factors from multiple families influence the
direction of the CREB regulatory response to the feeding/
fasting metabolic switch.Discussion
Reproducible ChIP-seq analysis in a tightly controlled
physiological system supports a model of constitutive
CREB DNA binding
Here, we employed ChIP-seq in the context of a controlled
fasting/re-feeding experiment — a robust model of CREB
activation downstream of the cAMP/PKA pathway — to
elucidate the role of CREB binding at specific sequence
elements in the regulation of fasting-responsive genes in
the liver. Our ChIP-seq data represent the first charac-
terization of CREB binding events across the entire gen-
ome in the mammalian liver. Previous studies of CREB
DNA binding in hepatocytes [6,14] were limited to known
proximal promoter regions and did not explore changes in
CREB occupancy. Our data reveal that CREB-DNA inter-
actions in the liver, many of which occur at thousands of
novel target genes missed by previous studies, are largely
independent of CREB activation by the cAMP/PKA path-
way in vivo, thus ruling out CREB DNA binding dynamics
as a determinant of cAMP-responsive genes.
We performed our ChIP-seq experiment with a higher
number of individual biological replicates than are typically
used in genome-wide location analysis, and developed a
novel peak-filtering strategy based on both computational
analysis and independent experimental confirmation of
reproducibility. In particular, our analysis demonstrates
that a peak height cut-off is an important additional filter
for ChIP-seq data, even when other stringent statistical
criteria are applied. Notably, our empirically determined
threshold was much lower than thresholds used in other
ChIP-seq analyses [28], highlighting the variability of such
attributes across different factors, antibodies, and sample
material. Thus, each ChIP-seq study currently requires
additional experimental validation to determine the opti-
mal peak height threshold. Interestingly, our experimen-
tally determined height cutoff (Additional file 1: Figure S2)
corresponds closely to the crossover point between peak
height distributions for those peaks passing or failing our
SSI test (Additional file 1: Figure S1C), suggesting that our
SSI test may provide a suitable model for determining the
Figure 7 Association of CREB binding sites with additional transcription factor occupancy at fasting-responsive genes. CREB sites were
separated into 3 groups: 285 sites associated with genes up-regulated in fasted state (red), 321 sites associated with genes down-regulated in
fasted state (green), 6,018 sites associated with genes that did not change (gray). A-F) Average ChIP-seq profiles around each group of CREB
binding sites are shown for CREB (A), CEBPB (B), NR3C1/GR (C), FOXA2 (D), PPARA (E), and CTCF (F). Corresponding distributions of peak heights
are shown as box plots in Additional file 1: Figure S7 and tabulated in Additional file 3. G) Percentage of sites in each group containing the
indicated motifs within +/− 250 bp of peak center. *p-value < 0.001 by Fisher’s exact test compared to gray bar.
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qPCR validation experiments.
We also demonstrated the importance of rigorous
quantitative analysis methods when comparing ChIP-seq
results across conditions. Using differences in peak calls
alone, as is done in typical Venn diagrams comparing
peaks called for a transcription factor or modified his-
tone in two or more conditions [27-29], can dramatically
over-state the differences between ChIP-seq profiles, and
result in thousands of erroneous calls of differentially
bound regions. In contrast, our quantitative analysis
revealed that CREB ChIP-seq profiles in the re-fed and
fasted states are tightly correlated genome-wide. Al-
though our analysis cannot rule out a weak globalinduction of CREB-DNA binding after fasting, it is im-
portant to note that only a few individual sites (0.2%)
showed a statistically significant difference in CREB oc-
cupancy between states (Additional file 1: Table S2). Of
these sites, only one was near a fasting-induced gene
(Mt1) on our microarray. Similarly, there was no signifi-
cant difference in binding for our ChIP-qPCR experiments
for cAMP/fasting-inducible CREB targets (Figure 2E), con-
firming that our ChIP-seq analysis was unlikely to be con-
founded by a lack of sensitivity or quantitative accuracy.
Therefore, we conclude that differential binding of CREB
in response to cAMP-induced phosphorylation is not a
widespread mechanism of fasting-induced gene expres-
sion, although the accessibility of a small set of CREB sites
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matin remodeling.
Previous in vitro studies had suggested that CREB-
DNA interactions were strengthened by CREB phos-
phorylation at S133, and that different classes of CRE
sequences showed different degrees of phosphorylation-
induced binding [7]. Our Western Blot analysis (Figure 1D)
confirms that in a controlled feeding experiment, S133
phosphorylation of CREB is indeed specific to the fasted
state, and therefore is likely to be involved in fasting-
induced gene activation as previously hypothesized [2,6,44].
Although work by Koo and colleagues showed that S133
phosphorylation of CREB in liver was unchanged after an
acute injection of insulin, used as a surrogate for the re-fed
state [5], this manipulation does not mimic the physio-
logical effects of re-feeding. Consistent with this notion, re-
cent work has shown that insulin injection and re-feeding
produce different results in terms of CREB co-factor re-
cruitment and target gene activation [15]. Thus, our data
support a model in which CREB is constitutively bound to
its target genes, and fasting/cAMP signals induce changes
in CREB phosphorylation and co-activator recruitment
that promote gene expression from a subset of CREB-
bound sites.
In the mammalian liver, the cAMP-induced phosphory-
lation of CREB S133 is known to enhance the recruitment
of co-activators CREBBP, CRTC2, and EP300, while both
CRTC2 and CREBBP are phosphorylated in response to
insulin signaling to inhibit their interactions with CREB
[5,16,45]. However, none of these co-activators have se-
quence specificity, as they are recruited to DNA indirectly
by CREB and many other transcription factors. Further-
more, previous ChIP-chip studies have suggested that
CREB phosphorylation on S133 occurs at the majority of
CREB binding sites and is not specific for cAMP-inducible
target genes [6]. Thus, other factors or genomic features
must influence the cAMP-responsiveness of specific CREB
target genes.
Novel CREB target genes in mammalian liver
Previous genomic analyses of CREB DNA binding in
liver cells were performed on human hepatocytes using
promoter tiling arrays [6,14]. A systematic comparison
of the target genes identified by our ChIP-seq study
against the study by Zhang and colleagues [6], which in-
cluded mapping of both gene symbols and homology
mapping of gene regions, revealed a strikingly small
overlap (only 14% of genes, Figure 3E). This undoubtedly
reflects, in part, evolutionary differences between mice
and humans. However, comparative ChIP-seq studies be-
tween mouse and human for other transcription factors
have demonstrated much higher overlap of target genes
(≥50%), even when the individual binding sites were not
well conserved [38,46]. Thus, the lower than expectedoverlap observed here likely also reflects the lower sensi-
tivity of the prior ChIP-chip study, which was limited to
only proximal promoter regions known at the time. Our
ChIP-seq study revealed sites in introns and distal up-
stream regions (Figure 3A), which were not included in
the previous ChIP-chip array design. Furthermore, Zhang
and colleagues estimated that their ChIP-chip study had
only ~50% sensitivity among the proximal promoter
regions [6].
Thus, our study reveals thousands of CREB target
genes that are novel within the context of the mamma-
lian liver. Roughly half of these genes were previously
observed as CREB target genes in genome-wide studies
of other cell types or predicted by bioinformatics
searches for functional CRE motifs [6,32], but our study
is the first to establish most of these genes as CREB tar-
gets in liver. The remaining genes, which total over
2,500, were not identified as CREB targets in any of the
genome-wide studies surveyed here. Many of these
genes, such as Creld2, B4galt5, and Onecut1/Hnf6, have
no known connection to CREB in the literature, but
have notably higher expression in re-fed livers compared
to fasted livers. Overall, our analysis has revealed new
functional roles for CREB, such as targeting ER stress
genes induced by the opposing switch from fasting to
feeding (Figure 5B, green bars).
Functionally distinct subsets of CREB binding sites specify
alternate responses to metabolic state
By integrating the CREB cistrome with fasting-dependent
gene expression changes, we identified genomic features
associated with the subset of CREB sites conferring cAMP-
inducible activation to nearby genes. Our genome-wide
analysis demonstrates that previously proposed elements,
such as promoter TATA boxes [18], are only weakly associ-
ated with fasting-responsive CREB target genes. Our inte-
grative analysis further revealed extensive co-localization at
individual regulatory elements by both CREB and add-
itional transcription factors CEBPB, NR3C1/GR, PPARA,
and FOXA2.
Our results expand on targeted studies of individual
gene promoters and suggest that synergistic interactions
between transcription factors are likely to play a genome-
wide role in the hepatic fed/fasted transcriptional switch.
For example, Zhang and colleagues previously showed that
liver-specific ablation of Foxa2 attenuated Pck1 induction
in response to cAMP in primary hepatocytes [8]. CEBPB
has been shown to directly activate Pck1 expression in a
manner dependent on the CREB binding site at the Pck1
promoter [20]. Christoffels and colleagues have shown
synergistic effects of NR3C1/GR agonist and cAMP on the
activity of an enhancer containing both CREB and GR
binding motifs upstream of Cps1 [37]. Our results here
suggest that such cross-talk occurs extensively within
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strongly associated with the specificity of the transcrip-
tional response to feeding/fasting transitions.
Surprisingly, we found that CREB-binding is associated
equally with feeding-induced genes as with fasting-induced
genes. There is no known mechanism by which CREB
might act as a transcriptional repressor. However, our re-
sults may reflect a feedback mechanism, in which some
fasting-induced CREB targets are silenced prior to the 24 hr
time point used in our experiment. Inducible cAMP early
repressor (ICER), a repressive protein resulting from an al-
ternate transcript of the CREB-related gene Crem, is a likely
candidate for this mechanism [44], and our CREB cistrome
confirms CREB binding at the alternate promoter of the
ICER transcript (Additional file 1: Figure S3C). Alterna-
tively, the subset of fasting-repressed genes might be
responding to a combination of CREB and a Maf factor
[43], as suggested by our de novomotif analysis (Figure 7G).
Another possibility is that genes with higher expres-
sion in re-fed livers are “feeding-induced”, rather than
“fasting-repressed”. The increased expression of ER stress
genes in re-fed livers supports this notion, as nutrient influx
has been shown to increase ER stress signals in liver and
other tissues [33,34]. Previous studies have shown that
CREB competes for CRTC2 with the ER stress-induced Ac-
tivating transcription factor 6 (ATF6), thereby providing an-
tagonism between nutrient-influx and nutrient-deprivation
signals [47,48]. Our novel observation that CREB also binds
many ER stress-induced genes may indicate a more direct
mechanism for this antagonism. Alternatively, CREB may
play a role in the transduction of both signals, with gen-
omic and epigenomic context determining the specificity of
each response. The additional connection between CREB
and ER stress revealed by our analysis is especially interest-
ing given the clinical observation that chronic ER stress
and overactive hepatic glucose production are both features
of type 2 diabetes and obesity [10,49,50].
Conclusions
Overall, our results demonstrate that CREB binding in
the mammalian liver is constitutive with respect to
metabolic state and widespread throughout the genome.
The mechanisms contributing to fasting-inducible ex-
pression changes at CREB target genes required for glu-
cose homeostasis are more complex than previously
appreciated. The majority of CREB target genes are not
induced by fasting and previously proposed mechanisms
for specifying this response — e.g., site-specific dynamic
occupancy [7] and interactions with TATA-containing
promoters [18] — do not sufficiently explain fasting-
responsive gene changes. The data presented above clearly
show that CREB co-localization with the additional tran-
scription factors CEBPB, NR3C1/GR, PPARA, and FOXA2
is specifically enriched around genes induced by fasting.Co-localization of these factors is significantly less frequent
at CREB sites around genes with lower expression after
fasting, suggesting a mechanistic difference between these
two groups of regulatory elements. Our integrated CREB
cistrome and fasting/re-feeding transcriptome provide es-
sential tools for further investigating the role of transcrip-




All mice used in this study were 8–12 week-old male
C57BL/6 J mice. All experiments were conducted under
a protocol approved by the IACUC of the University of
Pennsylvania.
Determination of blood glucose levels
Blood was sampled from the tail vein of fasted or re-fed
mice, and glucose levels were measured with a OneTouch
Ultra Glucometer (Lifescan Inc.).
RNA isolation and quantitative RT-PCR analysis
Total RNA was extracted from livers collected from
fasted and re-fed mice using the RNeasy Kit (Qiagen),
then assayed for quantity and quality with the Agilent
2100 Bioanalyzer (Agilent Technologies). RNA was reverse
transcribed using oligo (dT) and Superscript II reverse
transcriptase (Invitrogen). The resulting cDNA samples
were used as template for qPCR experiments performed
with SYBR GreenER qPCR Supermix (Invitrogen) and the
SYBR Green program on the Mx3000 Multiplex Quantita-
tive PCR System (Stratagene). Reactions were performed
in triplicate and normalized relative to the ROX reference
dye. Median cycle threshold values were used for analyses.
In each group, one sample had consistently higher thresh-
old values for all reactions indicating poor RNA isolation
quality, and was therefore excluded from analysis. Expres-
sion levels were normalized to those of Hypoxanthine
guanine phosphoribosyl transferase (HPRT) as the internal
control. Primer information is available at http://www.
med.upenn.edu/kaestnerlab/reagents.shtml.
Western blot analysis
Western blot analyses were performed as previously de-
scribed [16] using anti-phospho-CREB (Cell Signaling,
87G3/#9198) and anti-CREB (Cell Signaling, 48H2/
#9197) antibodies.
Expression microarray analysis
200 ng of total RNA from individual each fasted and re-
fed mouse livers (n = 4 per group) were amplified and
labeled with Cy3 or Cy5 using Low Input Quick Amp
Labeling Kit, two-color (Agilent, #5190-2306) with a dye
swap experimental design. Labeled samples were purified
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the Agilent 4X44 Whole Mouse Genome Array. After
hybridization the arrays were washed and scanned with the
Agilent DNA Microarray Scanner G2565B. Median inten-
sities of each array element were captured with Agilent Fea-
ture Extraction v10.5.1.1 and normalized by the print tip
loess method in LIMMA [51]. Differentially expressed gene
calls were performed by SAM [52] at 10% FDR and abso-
lute fold-change cutoff of 1.5. Raw microarray data is avail-
able through GEO under accession number GSE45731.
Chromatin Immunoprecipitation (ChIP)-sequencing
procedure
Liver chromatin from fasted and re-fed mice was prepared
as previously described [53]. Immunoprecipitations were
performed and ChIP-Seq libraries were prepared as previ-
ously described [16], using anti-CREB (Santa Cruz Biotech,
sc-186), anti-NR3C1/GR (mix of: Santa Cruz Biotech,
sc-1004 and Thermo Scientific, PA1-511A), and anti-
CEBPB (Santa Cruz Biotech, sc-150) antibodies. Libraries
for each mouse liver were sequenced individually on an
Illumina GAIIx. Raw sequencing data is available through
GEO under accession number GSE45674.
ChIP-seq peak calling
Reads for each individual ChIP-seq library were mapped
to the UCSC mm8 reference genome using Illumina’s
Eland pipeline. Redundant reads were discarded within
each replicate. For each condition (fasted, re-fed), non-
redundant reads from all five biological replicates were
pooled into a single read set, and initial peak-calling was
performed with HOMER v3.0 (5% FDR) [24], using a
large pool of previous experimental inputs as the back-
ground control. To identify peaks that are not dependent
on any single replicate, additional read subsets were
created by pooling every possible combination of four rep-
licates from each condition (fasted or re-fed), and peak-
calling was repeated with the same parameters. Initial
peak-calls from the 5-replicate pool were discarded if they
failed to be called in any of the 4-replicate pools (SSI test).
The entire SSI peak-calling procedure (using both the
complete 5-replicate sets and the 4-replicate subsets) was
also repeated with GLITR (5% FDR) [25] or MACS v1.4
(default parameters) with PeakSplitter v0.1 [26,54] in place
of HOMER, for the purpose of comparing algorithm per-
formance only. Venn diagrams of peak calls were gener-
ated with Cistrome [55]. HOMER peak calls passing SSI
filter were divided into quartiles by average peak height
across both conditions. Sites were randomly selected from
each quartile for ChIP-qPCR validation. For each selected
site, primers were designed and validated on input DNA
to confirm high amplification efficiency. Sites for which
efficient primers could be designed were subsequently
tested for CREB enrichment in two biological replicates ofchromatin from livers of 24 h fasted mice. Sites showing
average CREB enrichment >2-fold compared to 18S rDNA
control regions were considered as passing validation.
Based on this ChIP-qPCR validation, we applied a final
peak height threshold of 0.35 RPM to the set of remaining
CREB sites.
Differential binding analysis
To determine the extent of differential CREB binding
between the fasted and re-fed conditions genome-wide,
we first merged the fasted and re-fed SSI HOMER peak
calls with average height > 0.35 RPM to a common set
of 7,547 high-confidence binding regions. At each re-
gion, the peak height was computed individually for each
replicate by extending reads to the average fragment
length of 108 bp and computing the maximum value of
the resulting stack height profile within each binding re-
gion. Peak heights were normalized to RPM for each
replicate, and the normalized values were averaged to
compute a single value for each condition. The raw
number of tags from each replicate overlapping each
high-confidence peak was tabulated and used for statis-
tical analysis by EdgeR [30] with default parameters and
10% FDR after Benjamini-Hochberg p-value correction.
For comparison to other transcription factor ChIP-seq
data, the normalized peak height was computed at each
of the 7,547 high-confidence CREB sites to assess co-
localized binding, and peak height distributions were
compared across functional subsets of CREB sites. ChIP-
seq data for FOXA2 (GSE25836), PPARA (GSE35262),
and CTCF (GSE36027) are previously published and
available from GEO.
Motif analysis
Initial identification of consensus CRE sequences in each
binding region was performed by scanning the 100 bp
sequence around each site for the octamer TGACGTCA
with at most one mismatch, and the matching sequences
were classified as “Full CRE” sites. The remaining regions
were scanned for a perfect match to either pentamer half-
site CRE (TGACG or CGTCA), and matching sequences
were classified as “Half CRE” sites. The remaining regions
without a match to either CRE sequence were classified as
“Non-CRE” sites. De novo motif analysis was performed
using HOMER v3.0 [24] on the 100 bp (for whole
cistrome) or 500 bp (for regulation associated subsets) of
sequence around each site. Background genomic regions
were randomly selected using CisGenome [56] to maintain
the general distribution of distances from known transcrip-
tional start sites, and the HOMER parameter ‘-cpg’ was
used to normalize foreground and background sites by
CpG content. De novo motifs were filtered to significantly
enriched motifs matching ≥ 10% of target sequences. Po-
sitional motif enrichment plots were computed using the
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used the HOMER motif-scanning function with the known
TATA motif from JASPAR [57,58] to classify all genes as
TATA-containing or TATA-less. Specifically, we consid-
ered a gene to be TATA-containing if it contained a motif
hit with score ≥ 6 within 250 bp of the annotated TSS
position. This criteria showed clear enrichment of TATA
motifs 20-40 bp upstream of TSS, and resulted in roughly
20% of genes called as TATA-containing, in agreement
with previous assessments of TATA-containing promoters
[18,59,60].
Functional analysis
Binding regions were classified by their association with
known gene architecture by comparing the exact center
position of each region to the mm8 RefGene track
downloaded from UCSC Genome Browser [61]. Region
centers that were 2 kb upstream to 200 bp downstream
of a RefGene TSS were classified as “Promoter” regions.
Remaining region centers were classified based on over-
lapping RefGene introns, exonic coding regions, 5’UTRs
(>200 bp from TSS), and 3’UTRs. All other regions were
classified as “Intergenic”. CREB-bound genes are defined
as any gene with a high-confidence CREB peak center
within 10 kb upstream of the TSS or anywhere in the
gene body. To compare to CREB target genes from pre-
vious genome-wide studies, we mapped gene lists onto
our current RefGene annotations using both gene sym-
bols and by overlapping genomic coordinates, to avoid
any bias from updated gene annotations. For studies
performed in human cells, we mapped the correspond-
ing human promoter regions to the mouse genome using
the UCSC LiftOver utility [61]. For comparison to DHS
regions, we downloaded the DnaseI Digital Footprinting
Hotspots track in 8-week old mouse liver from ENCODE
[22,23] as mm9 coordinates, and mapped these regions to
mm8 using LiftOver.
Additional files
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Additional file 2: Summary tables of genes bound by CREB and
regulated in fasting/re-feeding microarray experiment.
Additional file 3: Summary table of all high-confidence CREB peaks,
including peak height in each replicate, nearest TSS, and enrichment
levels of additional transcription factors.
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